Jan Vilček
Jan Vilček earned his medical degree at Comenius University in Bratislava in 1957 and became one of the most influential biomedical scientists of his generation. A pioneer of interferon research, his work on antibodies against tumour necrosis factor helped lead to the anti-TNF drug used to treat rheumatoid arthritis and other autoimmune diseases. He became a professor at New York University and a major philanthropist for biomedical science.
































